Your browser doesn't support javascript.
loading
Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner.
Hoeft, Konrad; Schaefer, Gideon J L; Kim, Hyojin; Schumacher, David; Bleckwehl, Tore; Long, Qingqing; Klinkhammer, Barbara Mara; Peisker, Fabian; Koch, Lars; Nagai, James; Halder, Maurice; Ziegler, Susanne; Liehn, Elisa; Kuppe, Christoph; Kranz, Jennifer; Menzel, Sylvia; Costa, Ivan; Wahida, Adam; Boor, Peter; Schneider, Rebekka K; Hayat, Sikander; Kramann, Rafael.
Afiliação
  • Hoeft K; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Schaefer GJL; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Kim H; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Schumacher D; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany; Department of Anesthesiology, RWTH Aachen University, Aachen, Germany.
  • Bleckwehl T; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Long Q; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Klinkhammer BM; Department of Pathology, RWTH Aachen University, Aachen, Germany.
  • Peisker F; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Koch L; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Nagai J; Institute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany; Joint Research Center for Computational Biomedicine, RWTH Aachen University Hospital, Aachen, Germany.
  • Halder M; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Ziegler S; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Liehn E; Institute for Molecular Medicine, University of South Denmark, Odense, Denmark.
  • Kuppe C; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Kranz J; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany; Department of Urology, RWTH Aachen University, Aachen, Germany; Department of Urology and Kidney Transplantation, Martin-Luther-University, Halle (Saale), Germany.
  • Menzel S; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Costa I; Institute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany; Joint Research Center for Computational Biomedicine, RWTH Aachen University Hospital, Aachen, Germany.
  • Wahida A; Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Neuherberg, Germany; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Boor P; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Department of Pathology, RWTH Aachen University, Aachen, Germany.
  • Schneider RK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Cell Biology, Institute for Biomedical Technologies, RWTH Aachen University, Aachen, Germany.
  • Hayat S; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Kramann R; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany; Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, the Netherland
Cell Rep ; 42(2): 112131, 2023 02 28.
Article em En | MEDLINE | ID: mdl-36807143
ABSTRACT
Fibrosis represents the common end stage of chronic organ injury independent of the initial insult, destroying tissue architecture and driving organ failure. Here we discover a population of profibrotic macrophages marked by expression of Spp1, Fn1, and Arg1 (termed Spp1 macrophages), which expands after organ injury. Using an unbiased approach, we identify the chemokine (C-X-C motif) ligand 4 (CXCL4) to be among the top upregulated genes during profibrotic Spp1 macrophage differentiation. In vitro and in vivo studies show that loss of Cxcl4 abrogates profibrotic Spp1 macrophage differentiation and ameliorates fibrosis after both heart and kidney injury. Moreover, we find that platelets, the most abundant source of CXCL4 in vivo, drive profibrotic Spp1 macrophage differentiation. Single nuclear RNA sequencing with ligand-receptor interaction analysis reveals that macrophages orchestrate fibroblast activation via Spp1, Fn1, and Sema3 crosstalk. Finally, we confirm that Spp1 macrophages expand in both human chronic kidney disease and heart failure.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miofibroblastos / Macrófagos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miofibroblastos / Macrófagos Idioma: En Ano de publicação: 2023 Tipo de documento: Article